JP2008506632A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506632A5
JP2008506632A5 JP2006554374A JP2006554374A JP2008506632A5 JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5 JP 2006554374 A JP2006554374 A JP 2006554374A JP 2006554374 A JP2006554374 A JP 2006554374A JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5
Authority
JP
Japan
Prior art keywords
trp
azagly
asn
tyr
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006554374A
Other languages
English (en)
Japanese (ja)
Other versions
JP4346650B2 (ja
JP2008506632A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/012021 external-priority patent/WO2006001499A2/en
Publication of JP2008506632A publication Critical patent/JP2008506632A/ja
Publication of JP2008506632A5 publication Critical patent/JP2008506632A5/ja
Application granted granted Critical
Publication of JP4346650B2 publication Critical patent/JP4346650B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006554374A 2004-06-25 2005-06-23 メタスチン誘導体およびその用途 Expired - Fee Related JP4346650B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004187671 2004-06-25
JP2004363311 2004-12-15
PCT/JP2005/012021 WO2006001499A2 (en) 2004-06-25 2005-06-23 Metastin derivatives and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008245073A Division JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途

Publications (3)

Publication Number Publication Date
JP2008506632A JP2008506632A (ja) 2008-03-06
JP2008506632A5 true JP2008506632A5 (US20050137174A1-20050623-C00027.png) 2008-11-13
JP4346650B2 JP4346650B2 (ja) 2009-10-21

Family

ID=34971534

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006554374A Expired - Fee Related JP4346650B2 (ja) 2004-06-25 2005-06-23 メタスチン誘導体およびその用途
JP2008245073A Active JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008245073A Active JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Country Status (20)

Country Link
US (2) US7625869B2 (US20050137174A1-20050623-C00027.png)
EP (2) EP1758932A2 (US20050137174A1-20050623-C00027.png)
JP (3) JP4346650B2 (US20050137174A1-20050623-C00027.png)
CN (2) CN101863971A (US20050137174A1-20050623-C00027.png)
AR (1) AR049938A1 (US20050137174A1-20050623-C00027.png)
AU (1) AU2005257484A1 (US20050137174A1-20050623-C00027.png)
BR (1) BRPI0512397A (US20050137174A1-20050623-C00027.png)
CA (1) CA2571420A1 (US20050137174A1-20050623-C00027.png)
CL (1) CL2008003730A1 (US20050137174A1-20050623-C00027.png)
CR (1) CR8828A (US20050137174A1-20050623-C00027.png)
IL (1) IL179640A0 (US20050137174A1-20050623-C00027.png)
MA (1) MA28903B1 (US20050137174A1-20050623-C00027.png)
MX (1) MXPA06014206A (US20050137174A1-20050623-C00027.png)
NO (1) NO20065957L (US20050137174A1-20050623-C00027.png)
NZ (1) NZ552029A (US20050137174A1-20050623-C00027.png)
PE (2) PE20060371A1 (US20050137174A1-20050623-C00027.png)
RU (1) RU2006145886A (US20050137174A1-20050623-C00027.png)
SG (1) SG153865A1 (US20050137174A1-20050623-C00027.png)
TW (1) TW200607816A (US20050137174A1-20050623-C00027.png)
WO (1) WO2006001499A2 (US20050137174A1-20050623-C00027.png)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
WO2004063221A1 (ja) 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途
WO2004080479A1 (ja) 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤
RU2418633C2 (ru) 2004-04-08 2011-05-20 Байоматрика, Инк. Объединение процессов хранения образцов и управление образцами в медико-биологических науках
NZ552029A (en) 2004-06-25 2009-01-31 Takeda Pharmaceutical Metastin derivatives and use thereof
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
HUE028691T2 (en) 2005-09-14 2016-12-28 Mannkind Corp A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090093615A1 (en) * 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
WO2007125619A1 (ja) * 2006-04-26 2007-11-08 Kyoto University Gpr54アゴニスト活性を有する新規化合物
ITMI20061607A1 (it) 2006-08-09 2008-02-10 Maria Vincenza Carriero Peptidi con attivita farmacologica
UA94774C2 (en) * 2006-10-25 2011-06-10 Такеда Фармасьютикал Компани Лимитед Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
WO2009131191A1 (ja) * 2008-04-24 2009-10-29 武田薬品工業株式会社 メタスチン誘導体およびその用途
EP2275433B1 (en) * 2008-04-30 2017-06-07 Kyoto University Metastin derivative and use thereof
AR072114A1 (es) 2008-06-13 2010-08-04 Mannkind Corp Un inhalador de polvo seco y sistema para suministro de farmacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
BRPI0914308B8 (pt) 2008-06-20 2021-06-22 Mannkind Corp sistema de inalação
SI2314609T1 (sl) 2008-07-30 2017-05-31 Takeda Pharmaceutical Company Limited Derivat metastina in njegova uporaba
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
TW201029660A (en) * 2008-12-29 2010-08-16 Takeda Pharmaceutical Prophylactic/therapeutic agent for cancer
WO2010137022A1 (en) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
AR079657A1 (es) 2009-12-22 2012-02-08 Takeda Pharmaceutical Formulacion de liberacion sostenida
RU2571331C1 (ru) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
EP2598661B1 (en) 2010-07-26 2017-09-27 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2755690B1 (en) 2011-08-04 2020-04-01 Merck Sharp & Dohme B.V. Kisspeptide-pentasaccharide conjugates
JP6018640B2 (ja) * 2011-10-24 2016-11-02 マンカインド コーポレイション 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
EP2825548A4 (en) 2012-03-14 2016-02-24 Yeda Res & Dev MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
WO2014119753A1 (ja) * 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015112703A1 (en) * 2014-01-22 2015-07-30 The Johns Hopkins University Compositions and methods for treating diabetes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
CN113588501A (zh) 2015-12-08 2021-11-02 生物马特里卡公司 降低红细胞沉降速率
IL265696B1 (en) 2016-09-30 2024-04-01 Sumitomo Pharma Switzerland Gmbh -(n-acetyl-d-tyrosyl-trans-4-hydroxy-l-propyl-l-asparaginyl-l-threonyl-l-phenylalenyl) hydrazinocarbonyl-l-leucyl-nω-methyl-l-arginyl-l-tryptophanamide for use in assisted reproductive technology.
CN109206481B (zh) 2017-07-05 2023-08-18 尚华医药科技(江西)有限公司 一种肽类化合物、其应用及含其的组合物
CN108752233B (zh) * 2018-07-18 2020-10-16 河北师范大学 小分子凝胶因子、凝胶材料及制备方法和应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
FR2488253A1 (fr) * 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
IL74827A (en) 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE69623655T2 (de) 1995-10-19 2003-04-24 Takeda Chemical Industries Ltd Chinolinderivate als gnrh antagonisten
JPH09169735A (ja) 1995-10-19 1997-06-30 Takeda Chem Ind Ltd キノリン誘導体、その製造法および用途
AU2382097A (en) 1996-04-19 1997-11-12 Novo Nordisk A/S Compounds with growth hormone releasing properties
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
JP4486187B2 (ja) 1998-10-27 2010-06-23 武田薬品工業株式会社 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
IL147180A0 (en) 1999-06-28 2002-08-14 Basf Ag Method for preventing tumoral growth
US6638906B1 (en) 1999-12-13 2003-10-28 Nobex Corporation Amphiphilic polymers and polypeptide conjugates comprising same
JP2001231581A (ja) * 1999-12-17 2001-08-28 Takeda Chem Ind Ltd KiSS−1ペプチドの製造法
WO2001044469A1 (fr) 1999-12-17 2001-06-21 Takeda Chemical Industries, Ltd. PROCEDE DE PRODUCTION DE PEPTIDE KiSS-1
JP2004526401A (ja) 2000-03-29 2004-09-02 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
EP1273658A4 (en) 2000-03-30 2004-08-11 Takeda Chemical Industries Ltd NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF
US7834141B1 (en) 2000-03-31 2010-11-16 Theresa Siler-Khodr Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru) 2000-09-20 2007-12-10 Корикса Корпорейшн Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja) 2000-11-29 2003-01-29 Takeda Chem Ind Ltd 医薬組成物およびその製造法
JP2002320496A (ja) 2001-02-26 2002-11-05 Takeda Chem Ind Ltd 新規マウス型KiSS−1レセプタータンパク質およびそのDNA
WO2002085399A1 (en) 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Peptide-containing preparations
WO2002092829A1 (fr) 2001-05-17 2002-11-21 Takeda Chemical Industries, Ltd. Procede de production d'un peptide
EP1428835B1 (en) 2001-09-19 2007-04-18 Takeda Pharmaceutical Company Limited Antibody against metastin and use of the same in the diagnosis of pregnancy
EP1466976A4 (en) 2002-01-11 2005-11-09 Takeda Pharmaceutical PROCESS FOR PREPARING KISS-1 PEPTIDES
JP2003300906A (ja) 2002-04-12 2003-10-21 Daiichi Fine Chemical Co Ltd がん転移抑制因子の安定化
JPWO2004035089A1 (ja) * 2002-10-09 2006-02-09 協和醗酵工業株式会社 ホルモン依存性癌の治療剤
CA2503164A1 (en) 2002-10-25 2004-05-06 Paradigm Therapeutics Limited Gpr54 knock-out mammals and screening methods using them
JP4804714B2 (ja) 2002-12-26 2011-11-02 武田薬品工業株式会社 メタスチン誘導体およびその用途
WO2004063221A1 (ja) * 2002-12-26 2004-07-29 Takeda Pharmaceutical Company Limited メタスチン誘導体およびその用途
US6800611B2 (en) * 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Lk8 단백질을 유효성분으로 포함하는 항암제
WO2004080479A1 (ja) 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 性腺機能改善剤
EP1464652A1 (en) 2003-04-02 2004-10-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
US20050002935A1 (en) 2003-04-17 2005-01-06 Vincent Ling Use of B7-H3 as an immunoregulatory agent
US20050026224A1 (en) 2003-04-28 2005-02-03 Follettie Maximillian T. Methods and compositions for modulating G-protein coupled receptor 54
WO2004101747A2 (en) 2003-05-07 2004-11-25 The General Hospital Corporation Identification and use of gpr54 and its ligands for reproductive disorders and contraception
ATE399763T1 (de) 2003-05-30 2008-07-15 Prozymex As Proteasehemmer
RU2333221C2 (ru) 2003-11-03 2008-09-10 Бейцзин Санбио Байотек Ко., Лтд. Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
CA2544473C (en) 2003-11-03 2013-08-13 Beijing Sunbio Biotech Co., Ltd. A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
WO2005095973A2 (en) 2004-03-25 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
CA2562676A1 (en) 2004-04-23 2005-12-15 Applied Research Systems Ars Holding N.V. Use of gpcr54 ligands for the treatment of infertility
NZ552029A (en) * 2004-06-25 2009-01-31 Takeda Pharmaceutical Metastin derivatives and use thereof
WO2007084211A2 (en) 2005-11-11 2007-07-26 The General Hospital Corporation Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090093615A1 (en) * 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP2009530379A (ja) 2006-03-20 2009-08-27 メルク エンド カムパニー インコーポレーテッド ニューロメジンu受容体アゴニスト及びその使用
WO2007109857A1 (en) * 2006-03-28 2007-10-04 Biopharmica Ltd Agent for the treatment of hormone-dependent disorders and uses thereof
JO3048B1 (ar) * 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
WO2009044918A1 (ja) * 2007-10-05 2009-04-09 Takeda Pharmaceutical Company Limited ニューロメジンu誘導体
WO2009131191A1 (ja) 2008-04-24 2009-10-29 武田薬品工業株式会社 メタスチン誘導体およびその用途
EP2340047A1 (en) 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides

Similar Documents

Publication Publication Date Title
JP2008506632A5 (US20050137174A1-20050623-C00027.png)
JP2009520682A5 (US20050137174A1-20050623-C00027.png)
NL301202I2 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
JP2010501534A5 (US20050137174A1-20050623-C00027.png)
JP2006526031A5 (US20050137174A1-20050623-C00027.png)
JP2007522220A5 (US20050137174A1-20050623-C00027.png)
JP2005518413A5 (US20050137174A1-20050623-C00027.png)
NL300703I2 (nl) Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium.
EP1975149A4 (en) COMPOUND OF 1,3-BIS (SUBSTITUTED PHENYL) -3-HYDROXYPROPAN-1-ONE OR 2-PROPEN-1-ONE AND ITS SALT
JP2008514563A5 (US20050137174A1-20050623-C00027.png)
JP2010500116A5 (US20050137174A1-20050623-C00027.png)
JP2007119504A5 (US20050137174A1-20050623-C00027.png)
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
JP2007520565A5 (US20050137174A1-20050623-C00027.png)
JP2006339594A5 (US20050137174A1-20050623-C00027.png)
JP2009544651A5 (US20050137174A1-20050623-C00027.png)
JP2007520206A5 (US20050137174A1-20050623-C00027.png)
JP2004149545A5 (US20050137174A1-20050623-C00027.png)
DK1611884T3 (da) Plaster, indeholdende diclofenac
NL1030010A1 (nl) 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen.
JP2006506499A5 (US20050137174A1-20050623-C00027.png)
JP2003160581A5 (US20050137174A1-20050623-C00027.png)
JP2007523200A5 (US20050137174A1-20050623-C00027.png)